Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

Cited by (323)

Items 101–200 of 323

1. Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants
   Pontus Klein, Anne Kathrin Müller-Rischart, Elisa Motori, Cornelia Schönbauer, Frank Schnorrer, Konstanze F. Winklhofer, Rüdiger Klein · 2014 · The EMBO Journal
2. How Parkinson's disease meets nucleolar stress
   Rosanna Parlato, Birgit Liss · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
3. Mitochondrial quality control and neurological disease: an emerging connection
   Inês Pimenta de Castro, L. Miguel Martins, Roberta Tufi · 2010 · Expert Reviews in Molecular Medicine
4. The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effect
   Suzana Gispert, Alexander Kurz, Stefan Waibel, Peter Bauer, Inga Liepelt, Christof Geisen, Aaron D. Gitler, Tim Becker, Markus Weber, Daniela Berg et al. · 2011 · Neurobiology of Disease
5. Activation of AMPK/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death
   Yan, Qiuting, Han, Chaojun, Wang, Guanghui, Waddington, John L., Zheng, Longtai, Zhen, Xuechu · 2017 · Molecular Pharmacology
6. Targeting mitochondrial dysfunction in neurodegenerative disease: Part II
   Victoria Burchell, Sonia Gandhi, Emma Deas, Nicholas William Wood, Andrey Y. Abramov, Hélène Plun‐Favreau · 2010 · Expert Opinion on Therapeutic Targets
7. Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation
   Claudia Manzoni, Adamantios Mamais, Sybille Dihanich, Philip McGoldrick, Michael J. Devine, Julia Zerle, Eleanna Kara, Jan‐Willem Taanman, Daniel G. Healy, J.F. Martí-Massó et al. · 2013 · Biochemical and Biophysical Research Communications
8. Ubiquitin Hydrolase UCH-L1 Destabilizes mTOR Complex 1 by Antagonizing DDB1-CUL4-Mediated Ubiquitination of Raptor
   Sajjad Hussain, Andrew L. Feldman, Chittaranjan Das, Steven C. Ziesmer, Stephen Maxted Ansell, Paul J. Galardy · 2013 · Molecular and Cellular Biology
9. Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease
   Kiyoung Kim, Song‐Hee Kim, Jaekwang Kim, Heuijong Kim, Jeongbin Yim · 2012 · Journal of Biological Chemistry
10. Models of LRRK2-Associated Parkinson’s Disease
    Yulan Xiong, Ted M. Dawson, Valina Lynn Dawson · 2017 · Advances in neurobiology
11. The mitochondrial uncoupler <scp>DNP</scp> triggers brain cell <scp>mTOR</scp> signaling network reprogramming and <scp>CREB</scp> pathway up‐regulation
    Liu, Dong, Zhang, Yongqing, Gharavi, Robert, Park, Hee Ra, Lee, Jaewon, Siddiqui, Sana, Telljohann, Richard, Nassar, Matthew R., Cutler, Roy G., Becker, Kevin G. et al. · 2015 · Journal of Neurochemistry
12. Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease
    Eugénie Mutez, Aurore Nkiliza, Karim Bélarbi, Amélie de Broucker, Christel Vanbesien-Mailliot, Séverine Bleuse, Aurélie Duflot, Thomas Comptdaer, Pierre Semaille, Renaud Blervaque et al. · 2013 · Neurobiology of Disease
13. Mitochondrial dynamics and mitophagy in Parkinson's disease: A fly point of view
    Sophia von Stockum, Alice Nardin, Emilie Schrepfer, Elena Ziviani · 2015 · Neurobiology of Disease
14. Silent Information Regulator 2 (Sir2) and Forkhead Box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila PTEN-induced Kinase 1 (PINK1) Null Mutant
    Hyongjong Koh, Hyunjin Kim, Min Ju Kim, Jeehye Park, Hye-Jeong Lee, Jongkyeong Chung · 2012 · Journal of Biological Chemistry
15. PINK1 signalling in cancer biology
    Ciara H. O’Flanagan, Cora O’Neill · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
16. Autophagy in Dementias
    Christine Lund Kragh, Kiren K. Ubhi, Tony Wyss‐Coray, Eliezer Masliah · 2011 · Brain Pathology
17. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
    Lena F. Burbulla, Rejko Krüger · 2011 · Journal of the Neurological Sciences
18. Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease
    Khan, Mohammed Repon, Yin, Xiling, Kang, Sung-Ung, Mitra, Jaba, Wang, Hu, Ryu, Taekyung, Brahmachari, Saurav, Karuppagounder, Senthilkumar S., Kimura, Yasuyoshi, Jhaldiyal, Aanishaa et al. · 2023 · Science Translational Medicine
19. Crocin Reverses Depression-Like Behavior in Parkinson Disease Mice via VTA-mPFC Pathway
    Juanjuan Tang, Linyu Lu, Qisheng Wang, Hou Liu, Wenda Xue, Tong Zhou, Liantiao Xu, Kai Wang, Die Wu, Fei Wei et al. · 2020 · Molecular Neurobiology
20. Is Inhibition of Kinase Activity the Only Therapeutic Strategy for LRRK2-associated Parkinson's Disease?
    Iakov N. Rudenko, Ruth Chia, Mark Cookson · 2012 · BMC Medicine
21. Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson’s disease through AKT/mTOR pathway
    Liangqin Shi, Chao Huang, Qihui Luo, Yu Xia, Wentao Liu, Wen Zeng, Anchun Cheng, Riyi Shi, Chen Zhengli · 2020 · Aging
22. Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder
    Yuzuru Imai, Bingwei Lu · 2011 · Current Opinion in Neurobiology
23. Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy
    Xiang Bai, Margaret Wey, Elizabeth Fernández, Matthew J. Hart, Jonathan Gelfond, Alex F. Bokov, Sheela Rani, Randy Strong · 2015 · Pathobiology of Aging & Age-related Diseases
24. Increased translation as a novel pathogenic mechanism in Huntington’s disease
    Jordi Creus‐Muncunill, Raquel Badillos-Rodríguez, Marta García-Forn, Mercè Masana, Gerardo Garcia-Díaz Barriga, Anna Guisado-Corcoll, Jordi Alberch, Cristina Malagelada, Jose Maria Delgado-Garcia, Agnès Gruart et al. · 2019 · Brain
25. Molecular insights into Parkinson's disease
    Bobby Thomas, M. Flint Beal · 2011 · F1000 Medicine Reports
26. Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
    Colin Coleman, Ian Martin · 2022 · Journal of Parkinson s Disease
27. RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders
    Mercè Canal, Joan Romaní-Aumedes, Núria Martín‐Flores, Víctor Pérez-Fernández, Cristina Malagelada · 2014 · Frontiers in Cellular Neuroscience
28. Mitochondrial dysfunction induces dendritic loss via eIF2α phosphorylation
    Taiichi Tsuyama, Asako Tsubouchi, Tadao Usui, Hiromi Imamura, Tadashi Uemura · 2017 · The Journal of Cell Biology
29. Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
    Iakov N. Rudenko, Mark Cookson · 2014 · Neurotherapeutics
30. Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
    Srinivasa Reddy Bonam, Christine Tranchant, Sylviane Muller · 2021 · Cells
31. Drosophila ref(2)P is required for the parkin-mediated suppression of mitochondrial dysfunction in pink1 mutants
    Inês Pimenta de Castro, Ana Carolina Oliveira Costa, Ivana Celardo, Roberta Tufi, Dr David Dinsdale, Samantha H. Y. Loh, L. Miguel Martins · 2013 · Cell Death and Disease
32. Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
    Eran Tauber, Leonor Miller‐Fleming, Robert P. Mason, Wanda Kwan, Jannine Clapp, Nicola J. Butler, Tiago F. Outeiro, Paul J. Muchowski, Flaviano Giorgini · 2010 · Journal of Biological Chemistry
33. parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress
    Alec J. Vincent, L. Briggs, G. F. J. Chatwin, E. Emery, R. Tomlins, Matthew C. W. Oswald, C. A. Middleton, Gareth John Evans, Sean T. Sweeney, Christopher J. H. Elliott · 2012 · Human Molecular Genetics
34. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
    Lijun Dai, Miao Liu, Wei Ke, Liam Chen, Xin Fang, Zhentao Zhang · 2024 · Cellular and Molecular Life Sciences
35. mTOR Inhibition: From Aging to Autism and Beyond
    Matt R. Kaeberlein · 2013 · Scientifica
36. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
    Ravi Shankar Akundi, Lianteng Zhi, Hansruedi Büeler · 2011 · Neurobiology of Disease
37. Autophagy and Its Comprehensive Impact on ALS
    Chengyuan Song, Jifeng Guo, Yuan Liu, Beisha Tang · 2012 · International Journal of Neuroscience
38. Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis
    Taymans, Jean-Marc, Nkiliza, Aurore, Chartier-Harlin, Marie-Christine · 2015 · Trends in Molecular Medicine
39. Mitochondrial damage control
    Asa Abeliovich · 2010 · Nature
40. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease
    Joan Romaní-Aumedes, Mercè Canal, Núria Martín‐Flores, Xiaotan Sun, Víctor Pérez-Fernández, Sonja Wewering, Rubén Fernández‐Santiago, Mario Ezquerra, Claustre Pont‐Sunyer, Amàlia Lafuente et al. · 2014 · Cell Death and Disease
41. Progress in LRRK2-Associated Parkinson’s Disease Animal Models
    Steven P. Seegobin, George R. Heaton, Dongxiao Liang, Insup Choi, Marian Blanca Ramírez, Beisha Tang, Zhenyu Yue · 2020 · Frontiers in Neuroscience
42. Generation of high rapamycin producing strain via rational metabolic pathway‐based mutagenesis and further titer improvement with fed‐batch bioprocess optimization
    Zhu, Xiangcheng, Zhang, Wei, Chen, Xiyang, Wu, Hu, Duan, Yanwen, Xu, Zhinan · 2010 · Biotechnology and Bioengineering
43. Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
    Wongi Seol · 2010 · BMB Reports
44. Targeting Mitochondria for Neuroprotection in Parkinson's Disease
    Anthony H.V. Schapira · 2012 · Antioxidants and Redox Signaling
45. Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin
    Almas Siddiqui, Ingrid M. Hanson, Julie Kay Andersen · 2012 · Free Radical Research
46. Role of FOXO transcription factors in crosstalk between mitochondria and the nucleus
    Sujin Kim, Hyongjong Koh · 2017 · Journal of Bioenergetics and Biomembranes
47. Loss of PINK1 Attenuates HIF-1α Induction by Preventing 4E-BP1-Dependent Switch in Protein Translation under Hypoxia
    William Lin, Natasha L. Wadlington, Linan Chen, Xiaoxi Zhuang, James R. Brorson, Un Jung Kang · 2014 · Journal of Neuroscience
48. Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
    Di Hu, Zunren Liu, Xin Qi · 2021 · Frontiers in Neuroscience
49. Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target?
    Deborah C. I. Goberdhan · 2010 · PubMed
50. Neuroprotection in Parkinson's disease
    Anthony H.V. Schapira · 2009 · Parkinsonism & Related Disorders
51. Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions
    Robert E. Drolet, John M. Sanders, Jonathan T. Kern · 2011 · Journal of Neurogenetics
52. Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations
    Alzbeta Kralova Trancikova, Adamantios Mamais, Philip J. Webber, Klodjan Stafa, Elpida Tsika, Liliane Glauser, Andrew B. West, Rina Bandopadhyay, Darren J. Moore · 2012 · PLoS ONE
53. On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
    Veronique Daniëls, Veerle Baekelandt, Jean‐Marc Taymans · 2011 · Neurosignals
54. Comparative mRNA Expression of eEF1A Isoforms and a PI3K/Akt/mTOR Pathway in a Cellular Model of Parkinson’s Disease
    Kawinthra Khwanraj, Suriyat Madlah, Khwanthana Grataitong, Permphan Dharmasaroja · 2016 · Parkinson s Disease
55. What have we learned from Drosophila models of Parkinson’s disease?
    Ming Guo · 2010 · Progress in brain research
56. Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity
    Elena V. Nikonova, Yulan Xiong, Keith Quincy Tanis, Valina Lynn Dawson, Robert L. Vogel, Eva M. Finney, David J. Stone, Ian J. Reynolds, Jonathan T. Kern, Ted M. Dawson · 2011 · Human Molecular Genetics
57. PINK1 as a Molecular Checkpoint in the Maintenance of Mitochondrial Function and Integrity
    Hyongjong Koh, Jongkyeong Chung · 2012 · Molecules and Cells
58. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
    Verónica Galván, Matthew J. Hart · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
59. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia
    Mary K. Swinton, Aliyah Carson, Francesca Telese, Ana Beatriz Sánchez, Benchawanna Soontornniyomkij, Leila Rad, Isabella B. Batki, Brandi Quintanilla, Josué Pérez‐Santiago, Cristian L. Achim et al. · 2019 · Neurobiology of Disease
60. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases
    P. K. Annapoorna, Harish Iyer, Tanvi Parnaik, Harish Narasimhan, Arnav Bhattacharya, Arvind Kumar · 2019 · Neuroscience
61. Protein translation paradox: Implications in translational regulation of aging
    Harper S. Kim, Andrew M. Pickering · 2023 · Frontiers in Cell and Developmental Biology
62. ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease
    Manish Verma, Erin K. Steer, Charleen T. Chu · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
63. Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster
    Federica De Lazzari, Federica Sandrelli, Alexander J. Whitworth, Marco Bisaglia · 2020 · Antioxidants
64. Role of LRRK2 kinase dysfunction in Parkinson disease
    Azad Kumar, Mark Cookson · 2011 · Expert Reviews in Molecular Medicine
65. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
    Rory Coffey, Yuntao Shi, Marcus J. C. Long, Michael T. Marr, Lizbeth Hedstrom · 2016 · Journal of Biological Chemistry
66. Mitochondrial Dysfunction, Proteotoxicity, and Aging
    Alan R. Hipkiss · 2010 · Advances in clinical chemistry
67. Reappraisal to the study of 4E-BP1 as an mTOR substrate – A normative critique
    Asiya Batool, Sabreena Aashaq, Khurshid Iqbal Andrabi · 2017 · European Journal of Cell Biology
68. Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders
    Sonja K. Soo, Paige D. Rudich, Annika Traa, Namasthée Harris-Gauthier, Hazel J. Shields, Jeremy M. Van Raamsdonk · 2020 · Mechanisms of Ageing and Development
69. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
    Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
70. Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled protein glycation.
    Alan R. Hipkiss · 2010 · PubMed
71. LIN28A enhances the therapeutic potential of cultured neural stem cells in a Parkinson’s disease model
    Yong‐Hee Rhee, Taeho Kim, A. Young Jo, Mi‐Yoon Chang, Chang‐Hwan Park, Sang-Mi Kim, Jae‐Jin Song, Sang‐Min Oh, Sang‐Hoon Yi, Hyeon Ho Kim et al. · 2016 · Brain
72. Genetics and Pharmacology of Longevity
    Jorge Iván Castillo-Quan, Kerri J. Kinghorn, Ivana Bjedov · 2015 · Advances in genetics
73. Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila
    Caroline Fernandes, Yong Rao · 2011 · Molecular Brain
74. A transition to degeneration triggered by oxidative stress in degenerative disorders
    Michael Stern, James A. McNew · 2020 · Molecular Psychiatry
75. Models for LRRK2-Linked Parkinsonism
    Tianxia Li, Dejun Yang, Sarah Sushchky, Zhaohui Liu, Wanli Wei Smith · 2011 · Parkinson s Disease
76. Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
    Zhidong Zhou, Thevapriya Selvaratnam, Ji Chao Tristan Lee, Yinxia Chao, Eng‐King Tan · 2019 · Translational Neurodegeneration
77. The GATOR1 Complex Regulates Metabolic Homeostasis and the Response to Nutrient Stress in<i>Drosophila melanogaster</i>
    Wei, Youheng, Reveal, Brad, Cai, Weili, Lilly, Mary A · 2016 · G3 Genes|Genomes|Genetics
78. Novel models for Parkinson’s disease and their impact on future drug discovery
    Inés Trigo‐Damas, Natalia López‐González del Rey, Javier Blesa · 2018 · Expert Opinion on Drug Discovery
79. G-quadruplexes and associated proteins in aging and Alzheimer’s disease
    M. J. Vijay Kumar, Rodrigo Morales, Andrey S. Tsvetkov · 2023 · Frontiers in Aging
80. The impact of genetic research on our understanding of Parkinson’s disease
    Ian Martin, Valina Lynn Dawson, Ted M. Dawson · 2010 · Progress in brain research
81. The Second-Generation mTOR Kinase Inhibitor INK128 Exhibits Anti-inflammatory Activity in Lipopolysaccharide-Activated RAW 264.7 Cells
    Hao Pan, Lihui Xu, Dong‐Yun Ouyang, Yao Wang, Qing-bin Zha, Xiaofeng Hou, Xian‐Hui He · 2014 · Inflammation
82. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
    Federica Rizzo, Agnese Ramirez, Claudia Compagnucci, Sabrina Salani, Valentina Melzi, Andreina Bordoni, Francesco Fortunato, Alessia Niceforo, Nereo Bresolin, Giacomo P. Comi et al. · 2017 · Scientific Reports
83. Ferritin overexpression in Drosophila glia leads to iron deposition in the optic lobes and late-onset behavioral defects
    Stylianos Kosmidis, J Botella, Konstantinos Mandilaras, Stephan Schneuwly, Efthimios M. C. Skoulakis, Tracey Ann Rouault, Fanis Missirlis · 2011 · Neurobiology of Disease
84. Early-adulthood spike in protein translation drives aging via juvenile hormone/germline signaling
    Harper S. Kim, Danitra J. Parker, Madison M. Hardiman, Erin Munkácsy, Nisi Jiang, Aric N. Rogers, Yidong Bai, Colin S. Brent, James A. Mobley, Steven N. Austad et al. · 2023 · Nature Communications
85. Reduced insulin/insulin-like growth factor signaling decreases translation in Drosophila and mice
    Paul Essers, Luke Stephen Tain, Tobias Nespital, Joana Gonçalves, Jenny Fröhlich, Linda Partridge · 2016 · Scientific Reports
86. Attenuation of epigenetic regulator SMARCA4 and ERK‐ETS signaling suppresses aging‐related dopaminergic degeneration
    Ling V. Sun, Jie Zhang, Wenfeng Chen, Yun Chen, Xiaohui Zhang, Mingjuan Yang, Min Xiao, Fujun Ma, Yizhou Yao, Meina Ye et al. · 2020 · Aging Cell
87. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response
    Dastidar, Somasish Ghosh, Pham, Michael T., Mitchell, Matthew B., Yeom, Steven G., Jordan, Sarah, Chang, Angela, Sopher, Bryce L., La Spada, Albert R. · 2020 · The Journal of Neuroscience
88. Suppression of intestinal dysfunction in a Drosophila model of Parkinson’s disease is neuroprotective
    Giorgio Fedele, Samantha H. Y. Loh, Ivana Celardo, Nuno Santos Leal, Susann Lehmann, Ana Carolina Oliveira Costa, L. Miguel Martins · 2022 · Nature Aging
89. Proteomic Survey Reveals Altered Energetic Patterns and Metabolic Failure Prior to Retinal Degeneration
    Ana Griciuc, Michel Joseph Roux, Juliane Merl‐Pham, Angela Giangrande, Stefanie M. Hauck, Liviu Aron, Marius Ueffing · 2014 · Journal of Neuroscience
90. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
    Rubén Fernández‐Santiago, Núria Martín‐Flores, Francesca Antonelli, Catalina Cerquera‐Cleves, Verónica Moreno, Sara Bandrés‐Ciga, Elisabetta Manduchi, Eduard S. Tolosa, Andrew Singleton, Jason H. Moore et al. · 2019 · Movement Disorders
91. Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003
    Dutta, Subhasish, Basak, Bikram, Bhunia, Biswanath, Chakraborty, Samayita, Dey, Apurba · 2014 · 3 Biotech
92. Gene therapy: a viable therapeutic strategy for Parkinson’s disease?
    Alexander L. Berry, Thomas Foltynie · 2010 · Journal of Neurology
93. RNA metabolism in the pathogenesis of Parkinson׳s disease
    Bingwei Lu, Stephan Gehrke, Zhihao Wu · 2014 · Brain Research
94. Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture
    Radad, Khaled, Moldzio, Rudolf, Rausch, Wolf-Dieter · 2015 · Folia Neuropathologica
95. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease
    Yi Tan, Carmelo Sgobio, Thomas Arzberger, Felix Machleid, Qilin Tang, Elisabeth Findeis, Jörg Tost, Tasnim Chakroun, Pan Gao, Mathias Höllerhage et al. · 2019 · Acta Neuropathologica
96. Decoding Parkinson’s Disease Pathogenesis: The Role of Deregulated mRNA Translation
    Martin, Ian · 2016 · Journal of Parkinson’s Disease
97. Functional Pathway Identification With CRISPR/Cas9 Genome-wide Gene Disruption in Human Dopaminergic Neuronal Cells Following Chronic Treatment With Dieldrin
    Max Russo, Amin Sobh, Ping Zhang, Alex V. Loguinov, Abderrahmane Tagmount, Chris D. Vulpe, Bin Liu · 2020 · Toxicological Sciences
98. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
    Alexander J. Hull, Magda Luciana Atilano, Laith Gergi, Kerri J. Kinghorn · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
99. The mitochondrial kinase PINK1, stress response and Parkinson’s disease
    Marina Jendrach, Suzana Gispert, Filomena Ricciardi, Michael Klinkenberg, Rudolf Schemm, Georg W. J. Auburger · 2009 · Journal of Bioenergetics and Biomembranes
100. MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients
     Núria Martín‐Flores, Rubén Fernández‐Santiago, Francesa Antonelli, Catalina Cerquera‐Cleves, Verónica Moreno, Marı́a José Martı́, Mario Ezquerra, Cristina Malagelada · 2018 · Molecular Neurobiology